Rosiglitazone (RSG) improves glycemic control in poorly controlled, insulin-treated type 2 diabetes (T2D)

被引：0

|

作者：

Raskin, P

Dole, JF

Rappaport, EB

机构：

来源：

DIABETES | 1999年 / 48卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0404

引用

收藏

页码：A94 / A94

页数：1

相关论文

共 50 条

[1] Use of Statins in Patients with Insulin-Treated Type 2 Diabetes (T2D): Associations with Glycemic Control and Mortality Risks
Anyanwagu, Uchenna C.
Mamza, Jil B.
Idris, Iskandar
Donnelly, Richard
DIABETES, 2017, 66 : A433 - A433
[2] Rosiglitazone once or twice daily improves glycemic control in patients with type 2 diabetes (T2D)
Grunberger, G
Weston, WM
Patwardhan, R
Rappaport, EB
DIABETES, 1999, 48 : A102 - A102
[3] Bromocriptine-QR Improves Glycemic Control in Type 2 Diabetes (T2D) Subjects Poorly Controlled on High Dose Insulin Therapy
Chamarthi, Bindu
DIABETES, 2015, 64 : A309 - A309
[4] Low-dose rosiglitazone (RSG) provides additional glycemic control when combined with sulfonylureas in type 2 diabetes (T2D)
Gomis, R
Jones, NP
Vallance, SE
Patwardhan, R
DIABETES, 1999, 48 : A63 - A63
[5] Rosiglitazone improves insulin sensitivity find glycemic control in patients with both poorly controlled type 2 diabetes and hypertension
Sarafidis, PA
Lasaridis, AN
Pagkalos, E
Yovos, J
Kazakos, K
Mousleh, T
Tourkantonis, A
Nilsson, PM
DIABETES, 2005, 54 : A522 - A522
[6] Canagliflozin Improves Glycemic Control in Subjects with Type 2 Diabetes (T2D) Not Optimally Controlled on Stable Doses of Insulin
Schwartz, Sherwyn
Morrow, Linda
Hompesch, Marcus
Devineni, Damayanthi
Skee, Donna
Vandebosch, An
Murphy, Joe
Pfeifer, Michael
DIABETES, 2010, 59 : A154 - A154
[7] Rimonabant improves glycemic control in insulin-treated type 2 diabetes: The arpeggio trial
Hollander, Priscilla A.
Amod, Aslam
Litwak, Leon E.
DIABETES, 2008, 57 : A95 - A95
[8] The effects of metformin in poorly controlled insulin-treated type 2 diabetes mellitus
Aviles-Santa, L
Sinding, J
Raskin, P
DIABETES, 1998, 47 : A89 - A89
[9] IDegLira Improves Glycemic Control in Japanese Patients with Type 2 Diabetes (T2D) Uncontrolled on Premixed Insulin Therapy
Watada, Hirotaka
Agner, Bue F.
Doshi, Ankur
Gron, Randi
Ranthe, Mattis F.
Billings, Liana K.
DIABETES, 2019, 68
[10] Triple therapy with rosiglitazone (RSG) or insulin (INS) and associated medical resource use (MRU) and costs in type 2 diabetes (T2D)
Palmer, Liisa
Baser, Onur
Arondekar, Bhakti
Horblyuk, Ruslan
DIABETES, 2007, 56 : A650 - A650

← 1 2 3 4 5 →